Checkpoint Therapeutics (NASDAQ:CKPT – Get Free Report)‘s stock had its “hold” rating reiterated by equities research ...

Fintel reports that on March 11, 2025, HC Wainwright & Co. downgraded their outlook for Checkpoint Therapeutics ...

H.C. Wainwright downgraded Checkpoint Therapeutics (CKPT) to Neutral from Buy with a price target of $4.10, down from $20, following the ...

Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities ...

Shareholder law firm Julie & Holleman LLP is investigating the proposed $4.10 per share sale of Checkpoint Therapeutics ...

The brokerage firm Motilal Oswal had a ‘Buy call on three stocks on March 11. It has picked Sun Pharma after Checkpoint ...

Macquarie, Nomura, Kotak Institutional Equities, Kotak Institutional Equities, Morgan Stanley, HSBC ...

The country's top specialty generics company recently acquired US-based Checkpoint that will further its oncology portfolio ...

Shares of Sun Pharmaceutical Industries rose more than 3 per cent following ICICI Securities' upgrade of the stock to a 'Buy' ...

Five things you need to know in local business news to start your workday, including how Monday's stock market rout shaved $21 billion off five Massachusetts companies, plus more MGB layoffs, a ...

Full enrollment in cutaneous melanoma dose-expansion arms of Phase 1/1b clinical trial evaluating WTX-124 as monotherapy and in combination with pembrolizumab expected by the end of the first half ...